Premium
Nektar Therapeutics (NKTR)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| BVF Partners L.P. | Institution | 2 559 595 | 7,58% | US$ 167,37M | 2026-03-31 |
| Two Seas Global (Master) Fund Lp | Institution | 1 959 178 | 5,80% | US$ 128,11M | 2026-03-31 |
| Two Seas Capital LP | Institution | 1 959 178 | 5,80% | US$ 128,11M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 1 365 482 | 4,04% | US$ 89,29M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 997 300 | 2,95% | US$ 65,21M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 930 741 | 2,75% | US$ 60,86M | 2026-03-31 |
| Prosight Management, LP | Institution | 735 000 | 2,18% | US$ 48,06M | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 650 710 | 1,93% | US$ 42,55M | 2026-03-31 |
| Armistice Capital LLC | Institution | 578 000 | 1,71% | US$ 37,80M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 513 531 | 1,52% | US$ 33,58M | 2026-03-31 |
| Sofinnova Investments, Inc. | Institution | 509 546 | 1,51% | US$ 33,32M | 2026-03-31 |
| Woodline Partners LP | Institution | 415 335 | 1,23% | US$ 27,16M | 2026-03-31 |
| Lord, Abbett & Co. LLC | Institution | 405 080 | 1,20% | US$ 26,49M | 2026-03-31 |
| Millennium Management LLC | Institution | 404 277 | 1,20% | US$ 26,44M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 390 675 | 1,16% | US$ 25,55M | 2026-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 333 576 | 0,99% | US$ 21,81M | 2025-09-30 |
| Great Point Partners, LLC | Institution | 316 453 | 0,94% | US$ 20,69M | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 285 000 | 0,84% | US$ 18,64M | 2026-03-31 |
| 22NW, LP | Institution | 281 115 | 0,83% | US$ 18,38M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 275 000 | 0,81% | US$ 17,98M | 2026-03-31 |
| Gilder Gagnon Howe & Co. LLC | Institution | 271 758 | 0,80% | US$ 17,77M | 2026-03-31 |
| Nearwater Capital Markets, Limited | Institution | 261 500 | 0,77% | US$ 17,10M | 2026-03-31 |
| Braidwell LP | Institution | 222 701 | 0,66% | US$ 14,56M | 2026-03-31 |
| Patient Square Capital, LP | Institution | 210 000 | 0,62% | US$ 13,73M | 2026-03-31 |
| Bronte Capital Management Pty Ltd | Institution | 198 256 | 0,59% | US$ 12,96M | 2026-03-31 |
| Quinn Opportunity Partners LLC | Institution | 179 247 | 0,53% | US$ 11,72M | 2026-03-31 |
| Dafna Capital Management, LLC | Institution | 165 178 | 0,49% | US$ 10,80M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 161 252 | 0,48% | US$ 10,54M | 2026-03-31 |
| Biotechnology Value Trading Fund OS LP | Institution | 153 936 | 0,46% | US$ 10,07M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 131 733 | 0,39% | US$ 8,61M | 2024-12-31 |
| Creek Drive Management Group LLC | Institution | 126 400 | 0,37% | US$ 8,27M | 2026-03-31 |
| Squadron Capital Management Llc | Institution | 125 000 | 0,37% | US$ 8,17M | 2026-03-31 |
| Seven Grand Managers LLC | Institution | 125 000 | 0,37% | US$ 8,17M | 2026-03-31 |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | Institution | 122 326 | 0,36% | US$ 8,00M | 2026-03-31 |
| Squarepoint OPS LLC | Institution | 107 385 | 0,32% | US$ 7,02M | 2026-03-31 |
| Tetragon Partners UK LLP | Institution | 103 037 | 0,30% | US$ 6,74M | 2026-03-31 |
| Monashee Investment Management, LLC | Institution | 100 000 | 0,30% | US$ 6,54M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
